2
Total investments
1
Early stage
0
Mid stage
1
Late stage
17y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2015
Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Investor & Board Observer
Jun 2009
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
Experience · 6 entries
All (6)
Investments (2)
Founder (1)
Board (1)
2018
Executive Advisory Council
Feb 2018
New Mountain Capital (“New Mountain”) is an alternative investment manager with private equity, credit and net lease strategies. New Mountain’s aggregate assets under management total ~$50 billion across all investment strategies.* Since inception, New Mountain has raised over $27 billion of committed capital across six private equity funds. New Mountain was founded in 1999 by Steven B. Klinsky and today has ~245 employees, ~145 of which are investment professionals.
New Mountain’s efforts emphasize intensive fundamental research and a focus on growth and investor “value added,” rather than reliance on excessive risk, as the best path to high and consistent long-term returns. New Mountain has proactively developed particular research and operational expertise in carefully selected “defensive growth” niches of healthcare, health tech, life science supplies/biomanufacturing, “must have” information and data, digital marketing & transformation, infrastructure services/field services, specialized software, defensive growth consumer/products, financial services / technologies and technology-enabled business services. New Mountain Capital works systematically to establish expertise in additional sectors over time.
* Includes asset valuations and remaining commitments (if applicable) as of December 31, 2023 and undrawn capital as of December 31, 2023. Pro forma for capital committed as of April 1, 2024)
2015
Investor
2015
Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
2011
2009
Investor & Board Observer
Jun 2009
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
1996
C
Cardinal Partners
Managing General Partner
1996
Show all 6 entries ↓
